Iproclozide
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C11H15ClN2O2 |
Molar mass | 242.70 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Iproclozide |
Articles |
---|
Most recent articles on Iproclozide Most cited articles on Iproclozide |
Media |
Powerpoint slides on Iproclozide |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Iproclozide at Clinical Trials.gov Clinical Trials on Iproclozide at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Iproclozide
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Iproclozide Discussion groups on Iproclozide Patient Handouts on Iproclozide Directions to Hospitals Treating Iproclozide Risk calculators and risk factors for Iproclozide
|
Healthcare Provider Resources |
Causes & Risk Factors for Iproclozide |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Iproclozide (trade names Sursum, Sinderesin) is an irreversible and selective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was used as an antidepressant, but has since been discontinued.[1] It has been known to cause fulminant hepatitis and there have been at least three reported fatalities due to administration of the drug.[2][3]
See also
References
- ↑ Suerinck A, Suerinck E. (1966). "[Depressive states in a sanatorium milieu and monoamine oxidase inhibitors. (Therapeutic results by the combination of iproclozide and chlordiazepoxide). Apropos of 146 cases]". Journal de médecine de Lyon. 47 (96): 573–586. PMID 5930723.
- ↑ Pessayre D, de Saint-Louvent P, Degott C, Bernuau J, Rueff B, Benhamou JP. (1978). "Iproclozide fulminant hepatitis. Possible role of enzyme induction". Gastroenterology. 75 (3): 492–496. PMID 680506.
- ↑ Neil Kaplowitz, Laurie D. DeLeve (2003). Drug-induced liver disease. Informa Health Care. p. 455. ISBN 0-8247-0811-3. ISBN 9780824708115.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to watched fields
- Monoamine oxidase inhibitors
- Withdrawn drugs
- Phenol ethers
- Organochlorides
- Drug